Brief: Genscript Biotech Proposes Spin-Off And Separate Listing Of Probio Technology
04/09/2026 02:32
BRIEF-Genscript Biotech Proposes Spin-Off And Separate Listing Of Probio Technology Sept 4 (Reuters) - Genscript Biotech Corp 1548.HK:
PROPOSED SPIN-OFF AND SEPARATE LISTING OF PROBIO TECHNOLOGY LIMITED
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale